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Abstract
Background: Little is known about the physiological role of the EBER1 and 2 nuclear RNAs during
Epstein Barr viral infection. The EBERs are transcribed by cellular RNA Polymerase III and their
strong expression results in 106 to 107 copies per EBV infected cell, making them reliable diagnostic
markers for the presence of EBV. Although the functions of most of the proteins targeted by EBER
RNAs have been studied, the role of EBERs themselves still remains elusive.
Findings: The cellular transcription response to EBER2 expression using the wild-type and an
internal deletion mutant was determined. Significant changes in gene expression patterns were
observed. A functional meta-analysis of the regulated genes points to inhibition of stress and
immune responses, as well as activation of cellular growth and cytoskeletal reorganization as
potential targets for EBER2 RNA. Different functions can be assigned to different parts of the RNA.
Conclusion: These results provide new avenues to the understanding of EBER2 and EBV biology,
and set the grounds for a more in depth functional analysis of EBER2 using transcriptome activity
measurements.
Findings
Background
Epstein-Barr virus (EBV) is a member of the herpesvirus
family present in almost the entire human adult popula-
tion [1-3] and has been found to be associated with onco-
genesis of Burkitt's lymphoma, B- and T-cell leukemia/
lymphomas, nasopharyngeal carcinoma, breast cancer
and gastric cancer [4-7]. In EBV infected cells, several viral
genes are expressed of which the six nuclear antigens
(EBNAs 1–6), the three membrane proteins (LMP-1, -2A
and -2B) and the small non translated EBER1 and EBER2
RNAs are the most abundant [1,3].
The EBERs are transcribed by cellular RNA Polymerase III
(polIII) and their strong expression results in 106 to 107
copies per EBV infected cell [8,9], making them reliable
diagnostic markers for the presence of EBV. EBERs are
located in the nucleus [10] and have been shown to bind
to several cellular proteins, such as the La antigen [9,11-
14], the EBER-associated protein (EAP, now referred to as
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ribosomal protein L22) [15,16], and the interferon-induc-
ible protein kinase R (PKR) [17,18]. The binding of EBER1
to PKR blocks the PKR pathway resulting in the resistance
of the cell to Fas-mediated apoptosis [19]. Although the
functions of most of the proteins targeted by EBER RNAs
have been studied, the role of EBERs themselves still
remains elusive.
EBER-induced interleukin (IL)-10 expression in Burkitt's
lymphoma (BL) cells has been demonstrated [20]. IL-10 is
suggested to be an autocrine growth factor for BL cells
[21], and hence potentially links EBER expression to
hyperplastic transformation. Furthermore, a recent report
indicates that rather EBER2 than EBER1 plays a central
role in B-cell growth transformation [22]. Given this indi-
cation of a transcriptional response to EBER expression, as
well as the indication of the functional implication of
EBER2 in cellular transformation, we used microarrays to
assess transcriptome changes following expression of
EBER2 in HEK 293 cells.
Results and discussion
To obtain an EBER2 wild-type expression plasmid the
complete gene sequence including all polIII expression
elements from -156 to +195 was cloned into pUC18.
Since EBER backbones have been proposed as vehicles for
expression of short hairpin RNAs [23], we constructed an
EBER2 expression plasmid lacking the entire loop 2
(EBER2-L2) by introducing an AgeI restriction site at posi-
tion +142 which was then restricted and religated with the
naturally occurring XmaI site at position +77 (Figure 1).
The secondary structures of EBER2/EBER2-L2 were calcu-
lated [24] and illustrated in Figure 1. The two alternate
EBER2-L2 structures differ in their free energy by 3.1 kJ,
and retain the entire 5'3' stem structure (S) as well as the
entire or the upper part of the loop 1 (L1). Both constructs
a. Predicted secondary structure of the wild-type EBER2 RNA Figure 1
a. Predicted secondary structure of the wild-type EBER2 RNA. The 5'3' stem ("S"), and the two loops ("L1", "L2"), as 
well as the XmaI cloning site used to construct the EBER2-L2 mutant are indicated. b. Alternate predicted secondary struc-
tures for the EBER2-L2 RNA are illustrated. Labeling as in (a). Both structures differ minimally in their free energy (ΔG = 3.1 
kJ). c. Northern blot analysis of transfected HEK293 cells confirming the expression of both EBER2 constructs at comparable 
levels.
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express similar amounts of RNA as confirmed by northern
blotting using a specific 32P-labelled antisense RNA probe
that cross-hybridizes with both (Figure 1C).
First, we verified the absence of effects on cellular growth
or organization during ectopic expression of the RNAs.
Vectors that co-express EBER2/EBER2-L2 RNAs and green
fluorescent protein (GFP) were generated by inserting the
EBER2 constructs into the EcoO109I restriction site of
peGFP-N1 vector (Clontech). HEK293 cells cultured in
DMEM (Sigma) supplemented with 10% (v/v) Fetal
Bovine Serum (Bio West) at 7% CO2 and 37°C were trans-
fected using FUGENE-HD (Roche), and GFP positive cells
(~80%) were counted daily. Nuclei were stained with
Hoechst 33342 (Invitrogen), and Anti-Fibrillarin anti-
body (ab5821, Abcam) was used as a marker for nucleoli
by immunostaining of Fluoromount-G mounted cells.
Neither analysis revealed significant differences when
comparing EBER2, EBER2-L2 and mock (GFP only) trans-
fected cells (Figure 2). We also were not able to detect any
other significant changes in the morphology of the
HEK293 cells upon EBER2 expression.
For microarray analysis, HEK293 cells were transfected
with pUC18 vector or the EBER2/EBER2-L2 constructs by
calcium phosphate co-precipitation technique using the
initial constructs to avoid secondary effects by the co-
expression of GFP. Total RNA was extracted 48 h post-
transfection with an RNeasy Midi Kit (Qiagen), and ana-
lyzed for quality with an Agilent 2100 Bioanalyser. RNA
amplification, labeling, hybridization and detection were
done following the protocols supplied by Applied Biosys-
tems using 2 μg of total RNA as input. Labeled cRNAs were
then hybridized and detected on HGS Version 2.0 AB1700
microarrays containing probes for 29362 validated
human genes. The AB1700 technology has been demon-
strated to cover an increased signal dynamic range, display
higher sensitivity and provide more robust gene expres-
sion estimates when compared to the leading competing
technologies [25].
In this manner three independent biologic replicates
(independent transfections) for the pUC18 and EBER2
plasmids, and five independent biologic replicates for the
EBER2-L2 construct were generated. Expression Array Sys-
tem Software V1.1.1 (ProdNo: 4364137) was used to
acquire the images and primary data analysis. The homo-
geneity of the different biologic replicates was assessed
using heat-maps (Figure 3A) and average Pearson correla-
tion coefficients calculated over the entire set of ~34000
probes (Figure 3B). All three sets of experiments were
found to be highly reproducible as demonstrated by R2s of
at least 0.92, with 75% of the R2s being even superior to
0.95 (Figure 3B). Calculation of subtraction profiles was
performed according to standard procedures in an "every-
one-against-everyone" scheme and log2 fold-changes
("logQ", "L") where then determined as averages of vari-
ance-weighted individual logQ values using the
NeONORM method for normalization (Additional File 1;
M4) with parameter k = 0.20. P-values were determined
using standard ANOVA methodology. Multiple probes for
a single gene, cross-reactivity of a single probe to several
genes, as well as the resolution of probe-ID annotations
were according to previously defined standards (Addi-
tional File 1; M5).
Statistically significant changes in the HEK293 transcrip-
tome upon EBER2 or EBER2-L2 expression are observed
(Figure 3A). In the former case a total of 1218 probes are
found to detect differential gene expression at p < 0.01, of
which 137 are stimulated, and 1081 are repressed in their
expression when compared to mock (pUC18) transfected
cells. Thus EBER2 expression has a significant impact on
the cellular transcriptome. Likewise, the EBER2-L2 has a
very pronounced effect on cellular transcription. A total of
6269 probes are found to return statistically significant (p
< 0.01) differential signals, with the vast majority of genes
being repressed in their expression (6230 probes). Com-
parisons of both target gene sets (Additional Files 2, 3)
reveal that out of the 1218 EBER2 targets 962 (or 79%) are
also found to be EBER2-L2 targets (Venn-Diagrams, Fig-
ure 3A; Additional File 4). The clear majority of genes spe-
cific to EBER2 are up-regulated in their expression
indicating that positive transcription regulation requires
integrity of, and may be dependent directly on the L2
structure. The important number of genes negatively
affected in their transcription by EBER2-L2 is believed to
be a consequence of functionally unproductive titration
of cellular components leading to global repression of
RNA processing in the cell. Alternatively, albeit very
unlikely, we can not formally rule out the possibility that
EBER2 RNA or degradation products of the RNA interfere
with the transcriptome activity measurements. Such find-
ings have to be considered when using EBER2 RNA
sequences as a vehicle for the expression of shRNAs, as
recently proposed by Choy and colleagues [23].
Functional meta-analysis using Kegg/GO/PANTHER
ontologies for emergent properties of the two target gene
sets was performed using a binominal distribution and a
Bonferroni multiple testing correction. The joint EBER2/
EBER2-L2 target gene set is statistically significantly (p <
0.05) enriched in genes coding for components of the
"cytoskeletal regulation by rho GTPase" pathway (Figure
3C). Both RHOA and RHOC coding genes, as well as
CDC42 were found to be repressed across the eight inde-
pendent biologic replicates when compared to the mock
transfected cells, and have previously been shown to be
primordial in the cellular stress response pathway [26] by
orchestrating the regulation of cytoskeletal dynamics [27].BMC Research Notes 2008, 1:100 http://www.biomedcentral.com/1756-0500/1/100
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Absence of effects on cellular growth and subcellular organization by EBER2 expression Figure 2
Absence of effects on cellular growth and subcellular organization by EBER2 expression. a. Phase-contrast ("PC"), 
fluorescence ("GFP", "Hoechst"), and immunofluorescence ("α-Fibrillarin") for mock ("GFP") and EBER2 or EBER2-L2 trans-
fected HEK293 cells. b. Growth curves for the same cells. Averages and standard deviations of at least three independent 
transfections are shown.
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Concomitantly, we find other cellular components of the
cytoskeleton among the EBER2 target genes, such as the
actin related protein 2/3 complex family members 1B, 3,
and 5 [28], as well as the tubulin beta 2B and 4 family
members [29] along with other cytoskeletal components.
These data strongly suggest negative regulatory responses
of the rho-pathway following EBER2 expression (Figure 4;
Additional File 5).
The strong negative regulation by EBER2-L2 is explained
by over-representation (p < 1.00 E-9) of genes related to
mRNA maturation and protein synthesis in this dataset
(Figure 3D). EBER2-L2 likely interferes in a non-physio-
logical manner with the production and/or assembly of
the splicing and translation apparatuses, as the same proc-
esses are not overrepresented when the EBER2 target gene
set is analyzed. Furthermore, both EBER2 and EBER2-L2
might be processed by the RNA editing/degradation
machinery and give rise to molecules inferring with either
physiological processes, or, albeit highly unlikely, the
transcriptome analysis itself.
The EBER2 specific target gene repertoire also reveals
down-regulation of three highly related interferon induc-
ible trans-membrane proteins IFITM1, 2, 3, and induction
of several cellular growth regulators such as FGF receptor
3 and TGFβ receptor 3 [30]. The regulation of the latter is
observed only with EBER2 and therefore is directly assign-
able to L2 integrity (Figure 4). The main categories of
EBER2 targeted genes related to cellular growth, reorgani-
zation, and stress thereby seem to coincide well with pre-
vious advances in the understanding of EBER2 biology
[22]. The results here should therefore provide a novel,
complementary avenue to the understanding of EBER
RNAs and EBV physiopathology.
Conclusion
These investigations establish the feasibility of recording
transcriptome dynamics downstream of non-translated
small nuclear RNAs. Furthermore, they do not only point
to a role of EBER2 in regulating the activity of cellular
pathways related to growth and the cytoskeleton, as well
as negative interference into interferon mediated immune
responses and cellular stress, but also provide a basis for
the identification of the molecular targets of EBER2 RNA
and the understanding of the physiopathology of EBV, in
general. Regulating the activity of growth, cytoskeletal
dynamics as well as inhibition of cellular stress seems in
tune with recent advances in the understanding of EBER2
biology in the context of B-cell transformation [22].
Finally, these data should also prove very helpful in the
interpretation of results obtained using shRNA-EBER
fusion constructs as pioneered by Choy and colleagues
[23]. Given its high expression levels and structural stabil-
ity, EBER2, like other pol-III transcribed and/or viral RNAs
are being proposed as vehicles for the over-expression of
knock-down small interfering RNA species. The fact that
the backbone might, as shown here in the case of the
EBER2, have profound effects on the cellular transcrip-
a. Heat-maps of statistically significant (p < 0.01) changes in  gene expression when comparing EBER2/EBER2-L2 trans- fected to mock (pUC18) transfected cells at 48 h post-trans- fection Figure 3
a. Heat-maps of statistically significant (p < 0.01) 
changes in gene expression when comparing EBER2/
EBER2-L2 transfected to mock (pUC18) transfected 
cells at 48 h post-transfection. "L": log2(FoldChange), 
roman numbers indicate independent biologic replicates, "S": 
signal; "P": p-value. b. Average Pearson correlation coeffi-
cients of the transcriptome profiles of the biological repli-
cates. Homogeneity and reproducibility of the independent 
biologic replicates was assessed using Pearson correlation 
coefficients averaged over the common subset of ~34000 
probes. Pearson correlation coefficients larger than 0.950 
have been highlighted in dark green. c. Pathway analysis of 
the joint set of EBER2 and EBER2-L2 target genes. "Count": 
number of genes corresponding to a given pathway present 
in the selected dataset, "Total": total number of genes associ-
ated to given pathway, "Expect.": expected number of genes 
given the size of the selected dataset and a random zero-
hypothesis, "+:-": statistical over- (+) or under- (-) represen-
tation, "P-value": likelihood of zero-hypothesis to be correct. 
d. Biologic Process analysis of EBER2-L2 target genes. 
Nomenclature as in (b).BMC Research Notes 2008, 1:100 http://www.biomedcentral.com/1756-0500/1/100
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tome will certainly have to be studied during the valida-
tion of such hybrid molecules.
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